The community is debating the relevance of extreme self-experimentation, illustrated by the costly protocols of figures like Bryan Johnson, for advancing the science of longevity.

noli's read

The central debate concerns the scientific and ethical value of 'n=1' individual data versus the funding of large-scale fundamental research. Current research acknowledges that biomarker data tracked over the long term can offer interesting insights, but they suffer from a lack of statistical power and control compared to randomized clinical trials (RCT). While the rigorous monitoring of one's own constants (sleep, blood glucose, inflammation) can help optimize one's own biology, extrapolating these results to the entire population is scientifically premature. The community is largely favorable toward these initiatives (popularity consensus), perceiving these 'biohackers' as useful pioneers despite the absence of generalizable clinical evidence at this stage. It is important to distinguish personal optimization, which often relies on observational studies, from robust scientific validation. In sum, the approach is perceived as a potential driver of innovation, although its actual efficacy for extending human life beyond healthy standards remains an unproven hypothesis.

the sources

1. 1r/longevity